Submission on draft PBAC Guidelines

Mental Health Australia made a submission to the review of the Pharmaceutical Benefits Advisory Committee (PBAC) guidelines, calling on the guidelines to:

• Embed consumer and carer participation in app processes that affect them
• Ensure alignment with international best practice in consumer and carer participation in health technology assessment
• Invest in capacity building for consumer and carer participation
• Ensure careful consideration of the appropriate ‘comparator’ drug for mental health treatments
• Ensure that PBAC consider the broader benefits from medications, for example, consideration of the ability for the consumer and carer to return to the workforce